Kalaivani V, PhD
DHR-Young Scientist
Effect of Lipoprotein(a) in the Modulation of Early
Appearance of Calcification in the Placenta
I am trying to delineate the role of lipoprotein(a) [Lp(a)] on the onset and progression of pre-eclampsia. It is a pregnancy-mediated vascular disease occurs in association with hypertension and proteinuria. Pre-eclampsia shares many pathological events similar to that of cardiovascular diseases (CVDs). Both pre-eclamptic women and their offspring have an increased risk of developing future CVDs. Lipoprotein(a) [Lp(a)] is a circulating lipoprotein identical to low density lipoprotein. Lp(a) is unique in having a heavily O-glycosylated protein known as apolipoprotein(a). It is present only in humans. Higher plasma level of Lp(a) is an independent risk factor for both pre-eclampsia and CVDs. Moreover, Lp(a) deposits were found in both pre-eclamptic placenta and heart. As pre-eclampsia is a pre-disposing factor for CVDs in women, Lp(a) is considered as a possible connecting link between these two vascular diseases. But the underlying molecular mechanism is not known. In this context, my work specifically focuses on the pathological role of Lp(a) in pre-eclampsia.